Product Information

LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0750 per EA under NDC 29300019110. Its NADAC has been published 244 times since Dec 22, 2021.

FDA first approved this application on Jul 21, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB

losartan potassium and hydrochlorothiazide
$0.0750per EA

Strength

12.5; 100 mg/1; mg/1

NDC

29300019110

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204832

FDA Approved

7/21/2017

TE Code

AB

On Market Since

7/21/2017

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has been published 244 times since Dec 22, 2021, and over the history we have for it it has declined 58.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0750 per EA
All-time high$0.2088 (Apr 13, 2022)
All-time low$0.0742 (Jul 22, 2026)
52-week high$0.0973
52-week low$0.0742
Median price$0.1193
Average price$0.1160
Largest weekly change-24.9% (Nov 20, 2024)
Weeks tracked244
Tracking sinceDec 22, 2021

Price History

1W

+1.1%

1M

+1.1%

3M

-0.6%

6M

-3.5%

1Y

-23.0%

3Y

-40.4%

5Y

N/A

All

-58.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0750 per EA (NDC 29300019110), effective Aug 19, 2026.

How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has declined 58.1%. It has been tracked across 244 weekly CMS publications since Dec 22, 2021.

What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?

Since Dec 22, 2021, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has ranged from a low of $0.0742 (Jul 22, 2026) to a high of $0.2088 (Apr 13, 2022), with a median of $0.1193 per EA.

Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?

LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB (NDC 29300019110) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.